| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.64▼ | 4.64▼ | 4.65▼ | 5.16▼ | 7.39▼ |
| MA10 | 4.75▼ | 4.78▼ | 4.83▼ | 5.55▼ | 7.47▼ |
| MA20 | 4.90▼ | 4.91▼ | 5.06▼ | 7.86▼ | 9.50▼ |
| MA50 | 5.15▼ | 5.38▼ | 5.55▼ | 7.90▼ | 7.37▼ |
| MA100 | 5.48▼ | 5.92▼ | 7.33▼ | 9.77▼ | 4.00▲ |
| MA200 | 5.75▼ | 7.21▼ | 7.48▼ | 8.60▼ | 2.59▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.023▼ | -0.016▼ | -0.016▼ | -0.396▼ | -0.681▼ |
| RSI | 19.644▼ | 21.209▼ | 20.084▼ | 31.277▼ | 40.833▼ |
| STOCH | 1.641▼ | 1.831▼ | 1.623▼ | 3.220▼ | 34.099 |
| WILL %R | -94.318▼ | -95.146▼ | -96.000▼ | -99.332▼ | -99.392▼ |
| CCI | -90.407 | -96.932 | -107.259▼ | -76.506 | -157.383▼ |
|
Monday, April 20, 2026 04:17 AM
PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...
|
|
Wednesday, April 08, 2026 02:55 AM
Detailed price information for Passage Bio Inc (PASG-Q) from The Globe and Mail including charting and trades.
|
|
Wednesday, February 18, 2026 11:00 PM
PHILADELPHIA, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/05/26 | 4.91 | 5.01 | 4.52 | 4.57 | 83,389 |
| 01/05/26 | 5.06 | 5.155 | 4.828 | 4.97 | 24,950 |
| 30/04/26 | 5.32 | 5.4775 | 4.93 | 5.11 | 70,637 |
| 29/04/26 | 5.82 | 5.82 | 5.29 | 5.35 | 88,601 |
| 28/04/26 | 5.65 | 5.80 | 5.59 | 5.78 | 85,317 |
| 27/04/26 | 5.84 | 5.92 | 5.71 | 5.71 | 55,714 |
| 24/04/26 | 5.87 | 6.00 | 5.73 | 5.84 | 55,798 |
| 23/04/26 | 6.12 | 6.14 | 5.77 | 5.90 | 97,239 |
| 22/04/26 | 6.11 | 6.37 | 5.90 | 6.13 | 154,644 |
| 21/04/26 | 6.38 | 6.4399 | 5.75 | 6.18 | 396,727 |
|
|
||||
|
|
||||
|
|